CompaniesKiadis Pharma

Kiadis Pharma

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (12)
View all

Total Trials

12

As Lead Sponsor

10

As Collaborator

2

Total Enrollment

540

By Phase

PHASE1: 2PHASE1/PHASE2: 4PHASE2: 3PHASE3: 1PHASE2/PHASE3: 1

By Status

COMPLETED: 6WITHDRAWN: 3TERMINATED: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline12 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
NCT00993486
NCT01794299
NCT04220684
NCT04808115
Hover over trial bars to see details

Recent Trials

NCT04808115Collaborator
IIT PH1 KDS-1001 in Patients With CML
PHASE1Withdrawn
Started: Dec 31, 2024 · Completed: Dec 31, 2029
NCT04797975Lead Sponsor
Off-the-shelf NK Cells (KDS-1000) as Immunotherapy for COVID-19
PHASE1/PHASE2Withdrawn
Started: Dec 31, 2020 · Completed: Apr 30, 2021
NCT04395092Lead Sponsor
Haplo-identical Natural Killer (NK) Cells to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)
PHASE2Withdrawn
Started: Nov 13, 2020 · Completed: Nov 30, 2023
NCT04220684Collaborator
Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML
PHASE1Active, not recruiting
19 participants
Started: Jun 11, 2020 · Completed: Dec 31, 2025
NCT02999854Lead Sponsor
Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer
PHASE3Terminated
63 participants
Started: Nov 29, 2017 · Completed: Dec 17, 2021
View all 12 trials →
Funding History (1)
D
Jun 26, 2019
Filing
Related Companies
Sanofi
acquired